Defunct Company
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
6
NCT05348772
A First-In-Human Phase 1b Study of AmnioPul-02 in COVID-19 / Other LRTI
Phase: Phase 1
Role: Lead Sponsor
Start: Oct 10, 2022
Completion: Feb 9, 2023